De Novo
DEN240048: Spur Peripheral Retrievable Stent System
FDA De Novo · reflow medical, inc. · decided May 29, 2025
Key facts
| De Novo number | DEN240048 |
|---|---|
| Device name | Spur Peripheral Retrievable Stent System |
| Applicant | reflow medical, inc. |
| Product code | SEU |
| Date received | Sep 20, 2024 |
| Decision date | May 29, 2025 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Cardiovascular |
| FEI number | 3008789872 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: